RESUMO
A 31-year-old man was admitted to our hospital because of upper abdominal pain. He had been diagnosed with ulcerative colitis (UC) at age 28, but the disease has been in remission since then. On admission, he had slight fever, abdominal pain, and bloody stools six times a day, and the serum levels of pancreatic enzyme and IgG4 were elevated. Diffuse enlargement of the pancreas was detected by abdominal computed tomography; furthermore, narrowing of the main pancreatic duct was revealed using endoscopic retrograde cholangiopancreatography. Based on these findings, he was given a diagnosis of autoimmune pancreatitis (AIP) associated with UC. Both diseases improved without using steroids. After discharge, he has not had any recurrence of AIP or UC despite not being on steroid treatment, although the serum IgG4 level has shown a slight tendency to elevate.
Assuntos
Doenças Autoimunes/complicações , Colite Ulcerativa/complicações , Pancreatite/complicações , Adulto , Humanos , MasculinoRESUMO
Depletion of granulocytes and monocytes (GM) by selective apheresis (GMA) with an Adacolumn exerts an anti-inflammatory effect in patients with ulcerative colitis (UC) or rheumatoid arthritis. However, the mechanism of the anti-inflammatory effect of GMA is not fully understood yet. We investigated the effect of GMA on the plasma concentration of interleukin-1 receptor antagonist (IL-1ra), a potent anti-inflammatory cytokine. Twenty-six patients with active UC received GMA at one session per week for 5 consecutive weeks. Clinical response was defined as Deltaclinical activity index (DeltaCAI=CAI at entry - CAI at post)>or=4, while clinical remission was defined as CAIAssuntos
Colite Ulcerativa/sangue
, Colite Ulcerativa/imunologia
, Leucaférese/métodos
, Sialoglicoproteínas/sangue
, Adolescente
, Adulto
, Idoso
, Contagem de Células Sanguíneas
, Colite Ulcerativa/terapia
, Ensaio de Imunoadsorção Enzimática
, Feminino
, Granulócitos/patologia
, Granulócitos/fisiologia
, Humanos
, Proteína Antagonista do Receptor de Interleucina 1
, Masculino
, Pessoa de Meia-Idade
, Monócitos/patologia
, Monócitos/fisiologia
, Receptores de Interleucina-1/antagonistas & inibidores
, Receptores de Interleucina-1/fisiologia
, Indução de Remissão
, Índice de Gravidade de Doença
, Sialoglicoproteínas/fisiologia
, Resultado do Tratamento